St. Luke’s Hospital Selects Micromedex Information Solutions from Thomson Reuters for Clinical Decision Support

May 19, 2009

ANN ARBOR, Mich., May 19 /PRNewswire/ — St. Luke’s Hospital has signed an agreement to extend its use of Micromedex(R) healthcare solutions from Thomson Reuters as its key resource for clinical information.

St. Luke’s, a 493-bed, not-for-profit hospital in Chesterfield, Missouri, already makes extensive use of the Micromedex Healthcare Series for drug, toxicology, disease, alternative medicine, and patient education information. Under the new agreement, St. Luke’s will add clinical decision support tools from Micromedex to its physician portal and medication reconciliation tools.

“We conducted a comprehensive analysis of five vendors in this market, evaluating their products on clinical data, technology, and pricing. We found that Micromedex was the best value proposition for St. Luke’s,” said Scott Holtswarth, the hospital’s Director of Information Services. “From a technical perspective, a key differentiator was the ability of Micromedex to integrate its products with our current technology infrastructure. This includes our Intranet, bedside medication administration system, and a physician portal we developed in-house.”

“From a clinical perspective, Micromedex is a very timely and comprehensive resource, which is what clinicians need to make the best clinical decisions possible,” said Richard Fook, St. Luke’s Hospital Director of Pharmacy. “It’s also an excellent reference for patient education and medical education. Clinically, Micromedex offered the most comprehensive drug information database in a user-friendly format that will enhance our clinical decision support efforts.”

About Thomson Reuters

The Healthcare business of Thomson Reuters produces insights, information, benchmarks and analysis that enable organizations to manage costs, improve performance, and enhance the quality of healthcare. Thomson Reuters is the world’s leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, scientific, healthcare and media markets, powered by the world’s most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs more than 50,000 people in 93 countries. Thomson Reuters shares are listed on the New York Stock Exchange (NYSE: TRI); Toronto Stock Exchange (TSX: TRI); London Stock Exchange (LSE: TRIL); and Nasdaq (NASDAQ: TRIN). For more information, go to www.thomsonreuters.com.

About St. Luke’s Hospital

St. Luke’s Hospital, located in Chesterfield, Missouri, is a premier, regional healthcare provider specializing in individualized care. The 493-bed, not-for-profit hospital offers more than 60 specialty areas including cardiovascular care and surgery, cancer care, neurosurgery and neurology, orthopedics, maternity and other women’s health, general medicine, outpatient services, pediatrics and comprehensive surgical services. St. Luke’s Hospital was recognized in 2007, 2008, and 2009 as one of America’s 50 Best Hospitals by HealthGrades, a leading independent healthcare ratings company. St. Luke’s Hospital is the only healthcare facility in a ten-state region (Arkansas, Iowa, Kansas, Louisiana, Minnesota, Missouri, Nebraska, North Dakota, Oklahoma, and South Dakota) to be named one of America’s 50 Best Hospitals — ranking among the top one percent in the nation based on superior clinical quality over a nine-year time period. St. Luke’s Hospital is also a proud member of the Spirit of Women Hospital Network, a coalition of hospitals and healthcare providers across the United States that ascribe to the highest standards of excellence in women’s health, education and community outreach. For more information about St. Luke’s Hospital, please visit www.stlukes-stl.com/newsroom.

SOURCE Thomson Reuters Healthcare

Source: newswire

comments powered by Disqus